Live Breaking News & Updates on United Therapeutics Corporation Nasdaq

Stay updated with breaking news from United therapeutics corporation nasdaq. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Ferrer Secures Distribution Rights for Treprostinil, Targets IPF and PPF

Ferrer Secures Distribution Rights for Treprostinil, Targets IPF and PPF
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Comunidad Autonoma De Cataluna , Dominican Republic , United Kingdom , United Therapeutics Corporation Nasdaq , European Union , Business Development , United Therapeutics Corporation , Interstitial Lung Disease , Arterial Hypertension , Idiopathic Pulmonary Fibrosis , Progressive Pulmonary Fibrosis , Chief Scientific , Business Development Officer ,

Ferrer Obtains the Distribution Rights for Treprostinil Inhalation Solution Including the Potential Indications for Idiopathic Pulmonary Fibrosis IPF and Progressive Pulmonary Fibrosis PPF

The international pharmaceutical BCorp company Ferrer continues to strengthen its focus on pulmonary vascular and interstitial lung diseases by announcing the expansion of its current distribution agreement with United Therapeutics Corporation for Tyvaso a pharmaceutical drugdevice combination product authorized for the treatment of WHO Group 3 Pulmonary Hypertension associated with Interstitial Lung Disease PHILD and for WHO Group 1 Pulmonary Arterial Hypertension PAH. ....

United Kingdom , Comunidad Autonoma De Cataluna , Dominican Republic , Carlo Ferri , European Union , Business Development , United Therapeutics Corporation Nasdaq , United Therapeutics Corporation , Interstitial Lung Disease , Arterial Hypertension , Idiopathic Pulmonary Fibrosis , Progressive Pulmonary Fibrosis , Chief Scientific , Business Development Officer , Media Contact ,